meddevicedb.com FDA Device Reference

ALKPHASE-B ASSAY KIT

K981373 Class II Traditional
Decision Date
1998-05-27
Sponsor / Applicant
Metra Biosystems, Inc.

Technical Specification

510(k) Submission ID K981373
Product Code CIN
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1050
Decision Date 1998-05-27
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ALKPHASE-B ASSAY KIT received FDA 510(k) clearance under submission number K981373, sponsored by Metra Biosystems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1998-05-27.

Classification & Regulation

This clearance is catalogued under FDA product code CIN and 21 CFR 862.1050, within the Clinical Chemistry review panel as a Class II device.